Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin

Blood Cancer J. 2024 Aug 7;14(1):129. doi: 10.1038/s41408-024-01098-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use
  • Chemical and Drug Induced Liver Injury / diagnosis
  • Chemical and Drug Induced Liver Injury / etiology
  • Elasticity Imaging Techniques*
  • Female
  • Hepatic Veno-Occlusive Disease* / chemically induced
  • Hepatic Veno-Occlusive Disease* / diagnosis
  • Hepatic Veno-Occlusive Disease* / diagnostic imaging
  • Humans
  • Inotuzumab Ozogamicin* / adverse effects
  • Inotuzumab Ozogamicin* / therapeutic use
  • Liver / diagnostic imaging
  • Liver / drug effects
  • Liver / pathology
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Risk Assessment
  • Risk Factors

Substances

  • Inotuzumab Ozogamicin
  • Antineoplastic Agents, Immunological